Ovarian Cancer Series 09: How Is Ovarian Cancer Diagnosed?

A woman discusses her care with a clinician beside the headline How Is Ovarian Cancer Diagnosed? — Understanding the purpose of each test can make the next conversation easier.

Being sent for another test can make the answer feel decided before anyone has explained it. An ovarian mass, an abnormal blood result, or a specialist referral is not, by itself, a cancer diagnosis. The purpose of an ovarian cancer workup is to turn uncertainty into a clearer explanation and a plan.

This guide follows the questions that commonly arise during that process. Your appointments may overlap, and you may not need every test described here. Knowing what each test can answer can make the next conversation easier.

1. What actually confirms ovarian cancer?

Ovarian cancer is generally confirmed by examining a tissue sample, not by interpreting one scan or blood test alone. Before that, clinicians combine symptoms, examination findings, imaging, and laboratory results to decide what needs investigating. The route to a tissue diagnosis depends on the findings and the proposed treatment plan.

Think of the investigation as a series of questions, rather than a fixed package of tests. “What is causing these symptoms?” comes before “What treatment would help?” A useful question at any appointment is: “What decision will this result help us make?” NCI explains how different tests contribute to diagnosis.

This workup investigates symptoms or an abnormal finding. Screening, by contrast, looks for disease before symptoms develop. The same test name can appear in both discussions, but the purpose and interpretation differ.

Assessment	Main question
History and examination	What symptoms and clinical context need investigating?
Ultrasound	What does the pelvic mass look like?
Blood tests	What supporting information is available?
CT or selected MRI	What additional features or extent of disease need assessment?
Pathology	What is the tissue diagnosis?
Genetic and tumor testing	What might inform inherited risk or treatment?

This is a guide to the purposes of tests, not a checklist everyone must complete.

2. What happens at the first assessment?

The first assessment starts with your symptoms and medical history, often followed by an abdominal or pelvic examination. Your clinician may ask about menopause, previous conditions or operations, and cancers in your family. These details help guide further testing, but an examination alone cannot confirm or exclude ovarian cancer.

Bring a short account of what has changed for you. Instead of trying to find the perfect medical term, describe when a problem began and how it affects eating, sleep, work, or daily activities. A few specific examples can be easier to discuss than a long list of possible diagnoses.

Keep previous scan reports and a medication list together if you have them. If an examination worries you, ask the team to explain what will happen and discuss support or a chaperone. You can also use our guide to early ovarian cancer symptoms to help describe persistent changes.

3. What can an ultrasound tell you?

Pelvic ultrasound helps clinicians examine the ovaries and nearby structures, including the size and appearance of a mass. It may be performed through the abdomen, with a vaginal probe, or using both approaches. Ultrasound can identify features that need further assessment, but it does not provide a tissue diagnosis.

Published grayscale ultrasound image of a left ovarian cyst, with a large dark area surrounded by gray tissue. — Actual ultrasound image of a left ovarian cyst, described by its creator as approximately 5 cm. This illustrates what an ultrasound image looks like; it is not presented as a cancer diagnosis.
Image: James Heilman, MD / Wikimedia Commons, CC BY-SA 4.0. Unmodified.

Read the appointment instructions because preparation depends on the approach being used. If a vaginal examination causes concern, tell the team before it begins and ask about the procedure and your options. Your questions belong in the appointment, even when the test is familiar to the staff.

A report may use words such as “complex” without stating that cancer is present. Ask which finding matters most and whether the next step is observation, another scan, or specialist assessment. Our comparison of ovarian cysts and ovarian cancer explains why a mass and a malignancy are different descriptions.

4. Why are blood tests part of the workup?

A CA-125 blood test adds information to the overall assessment; it cannot diagnose ovarian cancer on its own. Some noncancerous conditions can raise the level, and some ovarian cancers do not produce a high result. Clinicians therefore interpret it alongside symptoms, imaging, and the rest of your medical information.

Other blood tests may check blood counts or kidney and liver function. Their purpose may be to understand your general health rather than to look for a cancer marker. Ask which results address the suspected mass and which help the team plan safe care.

When saving a result, keep the test name, date, units, and laboratory reference range together. Avoid reducing the whole assessment to one highlighted number in a portal. For a closer explanation of the marker's limits, read does a high CA-125 mean ovarian cancer? and the MedlinePlus CA-125 guide.

5. When are CT, MRI, and specialist review needed?

If findings raise concern, the next step may include a gynecologic oncologist and additional imaging. CT helps assess areas beyond the ovaries and supports planning. MRI may clarify selected findings, rather than being necessary for everyone. A referral signals a need for specialist judgment, not a confirmed diagnosis by itself.

When surgery is being considered for a suspicious mass, ask whether a gynecologic oncologist should be involved before the operation. The plan needs to account for both obtaining a diagnosis and what might be required if cancer is found. The American Cancer Society describes this specialist's role.

Use the scan appointment to clarify practical arrangements, too. Ask whether contrast is planned, what preparation is required, and which previous scans the team needs. Share relevant allergies, prior contrast reactions, and other health information requested by the imaging service; follow its individual instructions.

6. How is tissue obtained for diagnosis?

Tissue may be collected during an operation or through a separately planned biopsy. The choice depends on the suspected disease, its location, your health, and whether surgery or another treatment is expected first. A specialist team chooses the sampling approach; not every ovarian mass should follow the same biopsy pathway.

If surgery comes first, the removed tissue can establish the diagnosis. In other situations, an image-guided needle biopsy or laparoscopy may obtain tissue before treatment. When chemotherapy is being considered before surgery, confirming the diagnosis beforehand is a key part of planning. Cancer Research UK explains these different sampling routes.

Rather than comparing your sequence with someone else's, ask three practical questions. Where will the sample come from, why is that method suitable, and what happens if the sample does not answer the question? Write down the team's instructions for preparation and recovery, including whom to contact afterward.

It is also reasonable to ask when the result is expected and who will discuss it with you. Keep that contact information with the appointment details. A planned discussion is more useful than trying to interpret each new report in isolation.

7. What does the pathology report explain?

The pathology report identifies what was found in the sampled tissue and, if cancer is present, helps define its type. It may also describe grade and other features. Type, grade, and stage answer different questions, and additional testing or information from surgery may still be needed after an initial report.

Two H&E-stained micrographs of low-grade serous ovarian carcinoma, showing tissue at lower magnification on the left and cells at higher magnification on the right. — Actual H&E-stained tissue images of low-grade serous ovarian carcinoma at lower and higher magnification. This is one specific tumor subtype, from a different case than the ultrasound above; diagnosis requires a pathologist's assessment.
Image: Mikael Häggström / Wikimedia Commons, CC0 1.0. Unmodified.

🔬 Type describes the kind of cancer, including its histologic subtype. Grade concerns how the cells look under the microscope and their classification. Stage describes the extent of cancer in the body; it is not another name for grade.

Ask for the exact diagnosis in writing and check whether any additional results are pending. An addendum may arrive after the first report, so an early portal notification does not always contain every answer. The NCI pathology report guide explains the information these reports can contain.

For your notes, try two headings: “Confirmed now” and “Still being checked.” Put unfamiliar words in a separate question list rather than guessing their meaning. Bring both lists to the results appointment so the discussion starts with the uncertainties that matter most to you.

8. How are inherited genetic tests different from tumor tests?

Germline genetic testing looks for inherited changes, usually using blood or saliva, while tumor testing examines features of cancer cells. The two can inform different decisions about treatment and family risk. A BRCA change found in a tumor does not automatically prove it was inherited; further testing may be needed.

After an epithelial ovarian cancer diagnosis, genetic counseling and testing should be discussed even without a known family history. Ask whether the test being ordered concerns inherited risk, tumor characteristics, or both. NCI's BRCA fact sheet explains why inherited and tumor findings need careful interpretation.

Tumor biomarkers can help identify treatment options, but finding a marker does not guarantee that a treatment will work. A result called a variant of uncertain significance is also different from an established harmful variant. These distinctions should be explained by the team rather than treated as a reason to make changes on your own.

Keep the full reports, not just a screenshot of “positive” or “negative.” Ask who will explain the results and whether a genetics appointment is being arranged. The NCI biomarker testing guide provides a useful introduction to the treatment-related questions.

9. What should you organize before the next appointment?

Before leaving an appointment, aim to know what happens next, who is responsible, and when to make contact if you have not heard back. A clear follow-up plan is useful whether results are reassuring or further investigation is needed. It also gives you a route to report symptoms that persist or change.

A woman and her companion prepare notes and a folder for a medical appointment. — A short question list and a clear contact plan can help you stay organized.

A normal ultrasound does not mean ongoing symptoms should simply be ignored. If symptoms remain frequent or persistent, return to your clinician to discuss other possible causes and whether further assessment is needed. The NHS guidance on tests and next steps emphasizes this follow-up.

Results: Keep available reports together and note which results are still outstanding.
Changes: Write a few examples of what has improved, continued, or become different.
Questions: Choose your three most important questions so they are addressed early.
Support: If someone accompanies you, agree whether they will take notes or help ask questions.
Contact: Record the team's number, the expected update, and instructions for worsening symptoms.

You do not need to become an expert before asking for an explanation. Try summarizing the plan aloud: “This is what we know, and this is what we are checking next.” That small step can make a complicated sequence of appointments easier to follow.

Search This Blog

Wellness Trend Capsule